M Signore - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Signore

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Scientific Reports|February 10, 2016

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical OutcomeG Marziali, M Signore, M Buccarelli, et al.

Cell Death & Disease|May 10, 2014

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoM Signore, F Pelacchi, S di Martino, et al.

Cell Death and Differentiation|November 26, 2011

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapyM Bartucci, S Svensson, P Romania, et al.

Oncogene|February 14, 2017

C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisitionA Cannistraci, G Federici, A Addario, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Scientific Reports|February 10, 2016

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical OutcomeG Marziali, M Signore, M Buccarelli, et al.

Cell Death & Disease|May 10, 2014

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoM Signore, F Pelacchi, S di Martino, et al.

Cell Death and Differentiation|November 26, 2011

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapyM Bartucci, S Svensson, P Romania, et al.

Oncogene|February 14, 2017

C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisitionA Cannistraci, G Federici, A Addario, et al.

Pageof 3